First in-vivo trial of subharmonic contrast-enhanced imaging for detection of PCa

A new technique for imaging of microbubble ultrasound contrast agents may be useful in detection of prostate cancer (PCa) not found by multiparametric magnetic resonance imaging (MRI), according to a study to be presented at the ARRS 2019 Annual Meeting, set for May 5-10 in Honolulu, Hawaii.
Source: EurekaAlert, https://www.eurekalert.org